Nymox Pharmaceutical
NYMX
#10270
Rank
S$23.56 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.43 Million, an increase over its 2021 earnings that were of -S$16.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-63.98%
2022 -S$8.43 Million-47.71%
2021 -S$16.12 Million6.61%
2020 -S$15.12 Million-10.91%
2019 -S$16.97 Million24.24%
2018 -S$13.66 Million-20.03%
2017 -S$17.08 Million2.71%
2016 -S$16.63 Million-63.86%
2015 -S$46.01 Million674.44%
2014 -S$5.95 Million-6.11%
2013 -S$6.33 Million-35.66%
2012 -S$9.84 Million-20.76%
2011 -S$12.42 Million38.33%
2010 -S$8.98 Million35.59%
2009 -S$6.62 Million11.8%
2008 -S$5.92 Million-12.94%
2007 -S$6.8 Million8.85%
2006 -S$6.25 Million36.5%
2005 -S$4.58 Million-4.4%
2004 -S$4.79 Million-14.58%
2003 -S$5.61 Million
2001 -S$4.12 Million-20.54%
2000 -S$5.18 Million21.72%
1999 -S$4.25 Million-25.56%
1998 -S$5.71 Million101.3%
1997 -S$2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$43.31 B-1,552,714.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.15 B-471,733.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.93 B-391,863.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.22 B-1,190,803.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.70 B-61,090.28%๐Ÿ‡บ๐Ÿ‡ธ USA